S-GRAS score performs better than a model from SEER for patients with adrenocortical carcinoma. Issue 6 (21st June 2022)

• Record Type: Journal Article
• Authors: Lin, Wenhao; Dai, Jun; Xie, Jialing; Liu, Jiacheng; Sun, Fukang; Huang, Xin; He, Wei; Fang, Chen; Zhao, Juping; Xu, Danfeng
• Is Part Of: Endocrine connections. Volume 11:Issue 6(2022)
• Publication Date: 2022-06-21
• Subjects: S-GRAS score -- adrenocortical carcinoma -- survival -- prognostication; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EC-22-0114
• Languages: English
• ISSNs: 2049-3614

Abstract

Abstract : Purpose: To externally validate the performance of the S-GRAS score and a model from the Surveillance, Epidemiology, and End Results (SEER) database in a Chinese cohort of patients with adrenocortical carcinoma (ACC). Methods: We first developed a model using data from the SEER database, after which we retrospectively reviewed 51 ACC patients hospitalized between 2013 and 2018, and we finally validated the model and S-GRAS score in this Chinese cohort. Results: Patient age at diagnosis, tumor size, TNM stage, and radiotherapy were used to construct the model, and the Harrell's C-index of the model in the training set was 0.725 (95% CI: 0.682–0.768). However, the 5-year area under the curve (AUC) of the model in the validation cohort was 0.598 (95% CI: 0.487–0.708). The 5-year AUC of the ENSAT stage was 0.640 (95% CI: 0.543–0.737), but the Kaplan–Meier curves of stages I and II overlapped in the validation cohort. The resection status ( P = 0.066), age ( P =0.68), Ki67 ( P = 0.69), and symptoms ( P = 0.66) did not have a significant impact on cancer-specific survival in the validation cohort. In contrast, the S-GRAS score group showed better discrimination (5-year AUC: 0.683, 95% CI: 0.602–0.764) than the SEER model or the ENSAT stage. Conclusion: The SEER model showed favorable discrimination and calibration ability in the training set, but it failed to distinguish patients with various prognoses in our institution. In contrast, the S-GRAS score could effectively stratify patients with different outcomes.